Literature DB >> 21208658

Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia.

Wei Xu1, Yin-Hua Wang, Lei Fan, Cheng Fang, Dan-Xia Zhu, Dong-Mei Wang, Chun Qiao, Yu-Jie Wu, Jian-Yong Li.   

Abstract

The aim of this study was to explore the clinical and other associated laboratory features of chronic lymphocytic leukemia (CLL) patients with immunoglobulin (Ig) paraproteinemia. Serum protein electrophoresis (SPE) and immunofixation electrophoresis (IFE) were performed to measure serum Ig paraprotein. The correlations between serum Ig paraprotein and other prognostic factors were analyzed. Univariate and multivariate Cox regression analyses were used to assess associations between survival time and potential risk factors. In 133 Chinese CLL patients, 27 (20.3%) patients occurred Ig paraproteinemia at diagnosis. According to the correlation analysis, advanced Binet stage (r=0.314, P<0.001), direct antiglobulin test (DAT)-positive (r=0.366, P<0.001), high level of serum β2-microglobulin (β2-MG) (r=0.296, P=0.001) and thymidine kinase (TK) 1 (r=0.227, P=0.037), unmutated immunoglobulin heavy chain variable gene (IGHV) status (r=0.284, P=0.002), ZAP-70-positive (r=0.305, P=0.001), CD38-positive (r=0.284, P=0.002), and cytogenetic abnormalities of del(17p13) or del(11q22.3) (r=0.208, P=0.032) emerged as factors significantly related to the occurrence of Ig paraproteinemia. Survival analysis showed that the patients with Ig paraproteinemia had significantly shorter survival times than the patients without serum Ig paraprotein (P=0.013). Binet stage (P=0.028), high levels of lactate dehydrogenase (LDH) (P=0.004), IgG paraproteinemia (P=0.048), IgM paraproteinemia (P=0.001), ZAP-70-positive (P=0.003), DAT-positive (P=0.013), unmutated IGHV status (P=0.009), and del(17p13) (P=0.001) were the adverse factors in determining overall survival (OS). Del(17p13) (P=0.006), ZAP-70 (P=0.030), and IgM paraproteinemia (P=0.040) were the variables strongly associated with OS by multivariate Cox regression analysis. It was showed that serum Ig paraprotein might be applied for the assessment of prognosis in patients with CLL.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208658     DOI: 10.1016/j.leukres.2010.12.005

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events.

Authors:  D Rizzo; J Chauzeix; F Trimoreau; J B Woillard; F Genevieve; A Bouvier; J Labrousse; C Poli; E Guerin; N Dmytruk; L Remenieras; J Feuillard; N Gachard
Journal:  Leukemia       Date:  2014-06-19       Impact factor: 11.528

2.  Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.

Authors:  Panagiotis Baliakas; Anna Puiggros; Aliki Xochelli; Lesley-Ann Sutton; Florence Nguyen-Khac; Anne Gardiner; Karla Plevova; Eva Minga; Anastasia Hadzidimitriou; Renata Walewska; Helen McCarthy; Margarita Ortega; Rosa Collado; Teresa González; Isabel Granada; Elisa Luño; Jana Kotašková; Theodoros Moysiadis; Zadie Davis; Niki Stavroyianni; Achilles Anagnostopoulos; Jonathan C Strefford; Sarka Pospisilova; Frederic Davi; Anastasia Athanasiadou; Richard Rosenquist; David Oscier; Blanca Espinet; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2016-04-21       Impact factor: 9.941

3.  C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

Authors:  Ladan Zand; Andrea Kattah; Fernando C Fervenza; Richard J H Smith; Samih H Nasr; Yuzhou Zhang; Julie A Vrana; Nelson Leung; Lynn D Cornell; Sanjeev Sethi
Journal:  Am J Kidney Dis       Date:  2013-04-26       Impact factor: 8.860

4.  Case Report: Chronic Lymphocytic Leukemia With Recurrent Complement-Mediated Thrombotic Microangiopathy and C3 Glomerulonephritis.

Authors:  Tiantian Ma; Hui Wang; Tao Su; Suxia Wang
Journal:  Front Med (Lausanne)       Date:  2022-02-10

5.  Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL).

Authors:  Nicholas Wright; Ensi Voshtina; Gemlyn George; Arun Singavi; Joshua Field
Journal:  Int J Hematol       Date:  2019-09-07       Impact factor: 2.319

6.  Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.

Authors:  Jasmine Chauzeix; Marie-Pierre Laforêt; Mélanie Deveza; Liam Crowther; Elodie Marcellaud; Paco Derouault; Anne-Sophie Lia; François Boyer; Nicolas Bargues; Guillaume Olombel; Arnaud Jaccard; Jean Feuillard; Nathalie Gachard; David Rizzo
Journal:  Cancer Med       Date:  2018-05-09       Impact factor: 4.452

7.  The pathological features of leukemic cells infiltrating the renal interstitium in chronic lymphocytic leukemia/small lymphocytic lymphoma from a large single Chinese center.

Authors:  Hui Wang; Xiaojuan Yu; Xu Zhang; Suxia Wang; Minghui Zhao
Journal:  Diagn Pathol       Date:  2021-07-04       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.